The analyst lowered expectations for Januvia, Bridion, and ex-US Winrevair, while increasing projections for ... obesity treatment market by in-licensing a preclinical oral small molecule, GLP-1RA ...

The dosing regimen for Winrevair (sotatercept-csrk) is optimal for balancing efficacy and safety in adults with pulmonary arterial hypertension (PAH), an analysis of clinical trial data shows. This ...

Merck’s new 21-valent pneumococcal conjugate vaccine, Capvaxive, and pulmonary arterial hypertension drug, Winrevair, have the potential to generate significant revenues for Merck over the long ...

Bengaluru: Keros Therapeutics said on Wednesday it would voluntarily halt testing of an experimental blood pressure treatment due to safety concerns during a mid-stage trial, causing its shares to ...

and the ability of small molecule drugs to cross the placenta. It uses semi-supervised learning (SSL), a branch of machine learning that uses a small amount of labelled data to guide predictions ...

Additional growth drivers include promising launches like clesrovimab for RSV, Capvaxive for pneumococcal diseases, and expanding Winrevair’s revenue in Europe and the US. Additionally ...